Related Experiment Video
Updated: Feb 1, 2026
Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
Non-Malignant Imaging Changes Mimicking Local Tumour Progression of Renal Cell Carcinoma Following Percutaneous
Derek W Cool1, Cathal N O'Leary2, Satheesh Krishna3
1Division of Interventional Radiology, Department of Medical Imaging, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Objectives:
Local tumour progression (LTP) after percutaneous ablation of small renal cell carcinoma (RCC) is suspected when new enhancing or enlarging soft tissue appears within the ablation zone. Benign post-treatment changes can mimic this finding. This study compares the incidence and imaging characteristics of non-malignant changes (NMC) versus LTP after renal ablation.
Materials And Methods:
In this single-center, retrospective study, all patients with RCC treated with radiofrequency ablation (RFA) from February 2004 to May 2016 were identified. Post-ablation imaging reports from through May 2017 were reviewed to detect findings suspicious for LTP. Patients with suspicious findings underwent clinical, imaging, and histopathologic follow-up through May 2025 to determine the reference diagnosis. Imaging features were categorized by morphology, location within the ablation zone, and enhancement pattern.
Results:
Among 256 patients (mean age 65.6 years ± 10.8, 193 men) with 268 treated tumours, 18 tumours (6.7%) developed suspicious imaging findings. Eight tumours (3.0%) were classified as NMC and 10 tumours (3.7%) as LTP. NMC had significantly lower CT enhancement than LTP (31 vs 152 HU, P < .001). Lesions along the renal parenchymal margin were exclusively associated with LTP (9/9), whereas abnormalities at the extrarenal margin or centrally within the ablation zone were predominantly NMC (8/9). Enhancement with washout was seen only in LTP.
Conclusion:
Non-malignant post-ablation changes can mimic LTP and occur with similar frequency. Imaging features can help differentiate benign changes from local tumour progression and reduce unnecessary re-interventions.
More Related Videos
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:17Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:20Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
01:23Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
01:08Renal Drug Clearance: Comparison Between Renal Excretion Methods
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...